Sage Journals: Discover world-class research

Open access

Research article

First published 2020

Myasthenia Gravis Impairment Index: Sensitivity for Change in Generalized Muscle Weakness

Robert H.P. de Meel, Carolina Barnett, Vera Bril [...]

Journal of Neuromuscular Diseases

Open access

Research article

First published 2022

Prediction of the generalization of myasthenia gravis with purely ocular symptoms at onset: a multivariable model development and validation

Feng Li, Hongbin Zhang, Ya Tao [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2025

Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypes

Lei Jin, Zhangyu Zou, Qinzhou Wang [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2024

Effectiveness and safety of telitacicept for refractory generalized myasthenia gravis: a retrospective study

Jing Lin, Yue Li, Mengcui Gui [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2025

Appropriate use of steroids for patients with generalized Myasthenia Gravis: an international Delphi study

Heinz Wiendl, Hiroyuki Murai, Pushpa Narayanaswami [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2026

A Delphi consensus on integrating novel therapies into the management of generalized myasthenia gravis

John Vissing, Fritz Zimprich, Sari Atula [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2025-3

Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions

Vera Bril, Artur Drużdż, Julian Grosskreutz [...]

Journal of Neuromuscular Diseases

Free access

Research article

First published 2018

Efficacy of Rituximab in Refractory Generalized anti-AChR Myasthenia Gravis

Océane Landon-Cardinal, Diane Friedman, Marguerite Guiguet [...]

Journal of Neuromuscular Diseases

Open access

Research article

First published 2019

Do early prednisolone and other immunosuppressant therapies prevent generalization in ocular myasthenia gravis in Western populations: a systematic review and meta-analysis

Mingxia Li, Fangfang Ge, Rongjing Guo [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2025-3

Long-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension

Ali A Habib, Artur Drużdż, Julian Grosskreutz [...]

Journal of Neuromuscular Diseases

Search results